590 related articles for article (PubMed ID: 15613268)
1. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Marrone A; Dokal I
Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
[TBL] [Abstract][Full Text] [Related]
2. Dyskeratosis congenita: a genetic disorder of many faces.
Kirwan M; Dokal I
Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
[TBL] [Abstract][Full Text] [Related]
3. Dyskeratosis congenita: telomerase, telomeres and anticipation.
Marrone A; Walne A; Dokal I
Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
[TBL] [Abstract][Full Text] [Related]
4. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
Vulliamy TJ; Knight SW; Mason PJ; Dokal I
Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
[TBL] [Abstract][Full Text] [Related]
5. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
de la Fuente J; Dokal I
Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
[TBL] [Abstract][Full Text] [Related]
6. Dyskeratosis congenita: a disorder of defective telomere maintenance?
Walne AJ; Marrone A; Dokal I
Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
[TBL] [Abstract][Full Text] [Related]
7. Stem cells, telomerase and dyskeratosis congenita.
Mason PJ
Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
[TBL] [Abstract][Full Text] [Related]
8. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.
Ruggero D; Grisendi S; Piazza F; Rego E; Mari F; Rao PH; Cordon-Cardo C; Pandolfi PP
Science; 2003 Jan; 299(5604):259-62. PubMed ID: 12522253
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.
Vulliamy T; Beswick R; Kirwan M; Marrone A; Digweed M; Walne A; Dokal I
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8073-8. PubMed ID: 18523010
[TBL] [Abstract][Full Text] [Related]
10. A telomerase component is defective in the human disease dyskeratosis congenita.
Mitchell JR; Wood E; Collins K
Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
[TBL] [Abstract][Full Text] [Related]
11. Dyskeratosis congenita.
Handley TP; McCaul JA; Ogden GR
Oral Oncol; 2006 Apr; 42(4):331-6. PubMed ID: 16140563
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice.
He J; Navarrete S; Jasinski M; Vulliamy T; Dokal I; Bessler M; Mason PJ
Oncogene; 2002 Oct; 21(50):7740-4. PubMed ID: 12400016
[TBL] [Abstract][Full Text] [Related]
13. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.
Walne AJ; Vulliamy T; Marrone A; Beswick R; Kirwan M; Masunari Y; Al-Qurashi FH; Aljurf M; Dokal I
Hum Mol Genet; 2007 Jul; 16(13):1619-29. PubMed ID: 17507419
[TBL] [Abstract][Full Text] [Related]
15. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
Brault ME; Lauzon C; Autexier C
Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
[TBL] [Abstract][Full Text] [Related]
16. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
Vulliamy TJ; Dokal I
Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
[TBL] [Abstract][Full Text] [Related]
17. Dyskeratosis congenita.
Vulliamy T; Dokal I
Semin Hematol; 2006 Jul; 43(3):157-66. PubMed ID: 16822458
[TBL] [Abstract][Full Text] [Related]
18. Advances in the understanding of dyskeratosis congenita.
Walne AJ; Dokal I
Br J Haematol; 2009 Apr; 145(2):164-72. PubMed ID: 19208095
[TBL] [Abstract][Full Text] [Related]
19. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1.
Heiss NS; Bächner D; Salowsky R; Kolb A; Kioschis P; Poustka A
Genomics; 2000 Jul; 67(2):153-63. PubMed ID: 10903840
[TBL] [Abstract][Full Text] [Related]
20. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.
Vulliamy T; Marrone A; Szydlo R; Walne A; Mason PJ; Dokal I
Nat Genet; 2004 May; 36(5):447-9. PubMed ID: 15098033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]